Drug-drug interactions with tyrosine-kinase inhibitors

被引:2
作者
Croes, Sander [1 ,2 ]
de Vries, Frank [1 ,2 ,3 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, NL-6229 HX Maastricht, Netherlands
[2] Maastricht Univ, Sch Publ Hlth & Primary Care, CAPHRI, NL-6229 HX Maastricht, Netherlands
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands
关键词
D O I
10.1016/S1470-2045(14)70187-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E416 / E416
页数:1
相关论文
共 3 条
[1]   In Vitro Assessment of Time-Dependent Inhibitory Effects on CYP2C8 and CYP3A Activity by Fourteen Protein Kinase Inhibitors [J].
Filppula, Anne M. ;
Neuvonen, Pertti J. ;
Backman, Janne T. .
DRUG METABOLISM AND DISPOSITION, 2014, 42 (07) :1202-1209
[2]  
GlaxoSmithKline, PROD INF VOTRIENT OR
[3]   Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective [J].
van Leeuwen, Roelof W. F. ;
van Gelder, Teun ;
Mathijssen, Ron H. J. ;
Jansman, Frank G. A. .
LANCET ONCOLOGY, 2014, 15 (08) :E315-E326